|
|
| Session 15: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part III) |
|
Session Chair: Dr. Christian Jaulin, Group Leader, Cancer Research Center (CRLC) of Montpellier, France
Co-Chair: Dr. Robert J. Hickey, Indiana University School of Medicine, Department of Medicine, Indianapolis, Indiana, USA |
|
|
Title: A Novel Anti-cancer Agents that Target HIF-1a and HIF-2a for Cancer Therapy
Dr. Naijie Jing, Associate Professor, Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, USA
|
|
Title: The Mitotic Spindle Assembly Checkpoint: A New Therapeutic Target For Histone Deacetylase Inhibitors
Dr. Christian Jaulin, Group Leader, Cancer Research Center (CRLC) of Montpellier, France
|
|
Title: Targeting IGF-I Receptor to Treat Colorectal Cancer
Dr. Shi Yu Yang, Academic Department of Surgery, Royal Free & University College Medical School, University College London, UK
|
|
Title: Identification of a Cancer Specific Signature for Cancer: Diagnostic and Therapeutic Potential
Dr. Robert J. Hickey, Indiana University School of Medicine, Department of Medicine, Indianapolis, Indiana, USA
|
|
Title: Aberrant Epigenetic Modifications in Hepatocarcinogenesis Induced by Hepatitis B Virus X-Protein: A New Therapeutic Targets for DNA Methyltransferase Inhibitors
Dr. Young Ik Lee, Metabolic Syndrome Research Div.Korea Research Institute of Bioscience and Biotechnology (KRIBB), Taejeon, Korea
|
|